Pharmacovigilance
| Product | Date | Safety information | Attachments |
|---|---|---|---|
| Procoralan® (Ivabradine) |
Reminder on the Procoralan® (Ivabradine) conditions of use for the symptomatic treatment of chronic stable angina pectoris to avoid potentially dangerous bradycardia |
||
| Carvidol® (Carvedilol) |
Important safety update of prescribing information for Carvidol® (Carvedilol) |
||
| Vectibix® (Panitumumab) |
Rare cases of Stevens-Johnson syndrome and Toxic Epidermal Necrolysis that have been reported in patients treated with Vectibix® (Panitumumab) |
||
| Benlysta® (Belimumab) |
Two Post Marketing Reports, One Fatal, of Progressive Multifocal Leukoencephalopathy (PML) in Patients with Systemic Lupus Erythematosus (SLE) . |
||
| Plasmex 6%® (Hydroxyethyl starch) |
New safety guidance for Plasmex 6%® (Hydroxyethyl starch) |
||
| Plasmex 6%® (Hydroxyethyl starch) |
New safety guidance for Plasmex 6%® (Hydroxyethyl starch) |
||
| Valdoxan® - Agomelatine |
New contraindication for use and a reminder of importance of liver function monitoring. CLICK HERE |
||
| Roaccutane® - Isotretinoin |
Pregnancy Prevention Program and Safety Information about Roaccutane®. |
||
| VIREAD ® - Tenofovir |
Possible presence of silicone rubber in the above listed product and lots. |
||
| Zelboraf® - Vemurafenib |
Risk of liver injury reported with Zelboraf®. |
